Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum

• Published in: Magnetic resonance in medicine 2006-02, Vol.55 (2), p.302-308
• Main Authors: Sun, Shu-Wei, Liang, Hsiao-Fang, Trinkaus, Kathryn, Cross, Anne H., Armstrong, Regina C., Song, Sheng-Kwei
• Format: Article
• Language: English
• Subjects: Animals; axial diffusivity; axonal damage; Brain Chemistry; Corpus Callosum - pathology; Cuprizone - pharmacology; Demyelinating Diseases - chemically induced; demyelination; Diffuse Axonal Injury - chemically induced; Diffusion Magnetic Resonance Imaging; diffusion tensor imaging; Linear Models; Mice; Mice, Inbred C57BL; radial diffusivity; Statistics, Nonparametric
• ISSN: 0740-3194; 1522-2594
• DOI: 10.1002/mrm.20774

Previously, we tested the prediction that axonal damage results in decreased axial diffusivity (λ∥) while demyelination leads to increased radial diffusivity (λ⟂). Cuprizone treatment of C57BL/6 mice was a highly reproducible model of CNS white matter demyelination and remyelination affecting the corpus callosum (CC). In the present study, six C57BL/6 male mice were fed 0.2% cuprizone for 12 weeks followed by 12 weeks of recovery on normal chow. The control mice were fed normal chow and imaged in parallel. Biweekly in vivo DTI examinations showed transient decrease of λ∥ in CC at 2–6 weeks of cuprizone treatment. Immunostaining for nonphosphorylated neurofilaments demonstrated corresponding axonal damage at 4 weeks of treatment. Significant demyelination was evident from loss of Luxol fast blue staining at 6–12 weeks of cuprizone ingestion and was paralleled by increased λ⟂ values, followed by partial normalization during the remyelination phase. The sensitivity of λ⟂ to detect demyelination may be modulated in the presence of axonal damage during the early stage of demyelination at 4 weeks of cuprizone treatment. Our results suggest that λ∥ and λ⟂ may be useful in vivo surrogate markers of axonal and myelin damage in mouse CNS white matter. Magn Reson Med, 2006. Published 2006 Wiley‐Liss, Inc.